Heart health

FILE - In this Dec. 12, 2002 file photo, Dr. JoAnn Manson poses with a printout from a study she directed on hormone replacement therapy for women at her office in Boston. In research results released on Tuesday, Sept. 12, 2017, Manson said hormones may be appropriate for some women when used short-term to relieve hot flashes and other bothersome menopause symptoms. (AP Photo/Elise Amendola)
September 12, 2017 - 11:39 am
CHICAGO (AP) — Taking hormone pills for several years after menopause didn't shorten older women's lifespans, according to the longest follow-up yet of landmark research that transformed thinking on risks and benefits of a once popular treatment. That research was halted early when unexpected harms...
Read More
FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab's maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File)
August 27, 2017 - 5:03 am
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years. People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an...
Read More
FILE - This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades. Canakinumab's maker, Novartis, sponsored the study. (Georgios Kefalas/Keystone via AP, File)
August 27, 2017 - 5:00 am
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol. Many heart attacks occur in people who have normal cholesterol but high inflammation, which can lead to clogged arteries. A study tested the Novartis...
Read More
In this July 31, 2017 photo provided by Oregon Health & Science University, Shoukhrat Mitalipov, left, talks with research assistant Hayley Darby in the Mitalipov Lab at OHSU in Portland, Ore. Mitalipov led a research team that, for the first time, used gene editing to repair a disease-causing mutation in human embryos, laboratory experiments that might one day help prevent inherited diseases from being passed to future generations. (Kristyna Wentz-Graff/Oregon Health & Science University via AP)
August 02, 2017 - 1:41 pm
WASHINGTON (AP) — Altering human heredity? In a first, researchers safely repaired a disease-causing gene in human embryos, targeting a heart defect best known for killing young athletes — a big step toward one day preventing a list of inherited diseases. In a surprising discovery, a research team...
Read More
FILE - In this May 17, 2017 file photo, Rep. Elijah Cummings, D-Md. speaks during a news conference on Capitol Hill in Washington. Cummings has undergone a heart procedure and will remain hospitalized for a few days. (AP Photo/Alex Brandon, File)
May 25, 2017 - 10:53 am
WASHINGTON (AP) — The top Democrat on the House Oversight and Government Reform Committee has undergone a heart procedure and will remain hospitalized for a few days. That's the word from Rep. Elijah Cummings of Maryland. He says in a statement that he had what he calls a "minimally invasive...
Read More
May 23, 2017 - 9:32 am
GENEVA (AP) — The Latest on the World Health Organization's new chief (all times local): 3:30 p.m. Pakistan's candidate to be the next director-general of the World Health Organization, cardiologist Dr. Sania Nishtar, said she decided to go into public health after being told the hospital where she...
Read More
FILE - This Feb. 27, 2017, file photo shows Jimmy Kimmel, left, and his pregnant wife Molly McNearney at the Vanity Fair Oscar Party in Beverly Hills, Calif. The hole-in-the-heart problem that plagues comedian Jimmy Kimmel's newborn son is one of the most common heart-related birth defects, and it usually can be fixed with surgery. On his show Monday night, the comedian tearfully described the emergency operation needed after his son, William John, was born on April 21. (Photo by Evan Agostini/Invision/AP, File)
May 02, 2017 - 7:28 pm
The hole-in-the-heart problem that plagues comedian Jimmy Kimmel's newborn son is one of the most common heart-related birth defects, and it usually can be fixed with surgery. Some people even live with it for several years before it's detected although the Kimmel baby's is the most severe form and...
Read More
May 02, 2017 - 3:59 pm
WASHINGTON (AP) — No. 2 Senate Democrat Dick Durbin is recovering in Illinois after an outpatient procedure for an irregular heartbeat. Durbin was recently diagnosed with atrial flutter, a common, non-life threatening condition in which the heart beats less efficiently but one in which symptoms are...
Read More
FILE - This Feb. 27, 2017, file photo shows Jimmy Kimmel, left, and his pregnant wife Molly McNearney at the Vanity Fair Oscar Party in Beverly Hills, Calif. The hole-in-the-heart problem that plagues comedian Jimmy Kimmel's newborn son is one of the most common heart-related birth defects, and it usually can be fixed with surgery. On his show Monday night, the comedian tearfully described the emergency operation needed after his son, William John, was born on April 21. (Photo by Evan Agostini/Invision/AP, File)
May 02, 2017 - 2:25 pm
The hole-in-the-heart problem that plagues comedian Jimmy Kimmel's newborn son is one of the most common heart-related birth defects, and it usually can be fixed with surgery. Some people even live with it for several years before it's detected although the Kimmel baby's is the most severe form and...
Read More
April 25, 2017 - 5:56 am
GENEVA (AP) — Swiss pharmaceuticals group Novartis says net income fell 15 percent in the first quarter as it continued to adjust to generic competition for its Gleevec leukemia drug and stopped work on a hoped-for treatment for heart failure. The Basel-based company said net income dropped to $1.7...
Read More

Pages